Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Nazzani

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 28, 2022
Laparoscopic retroperitoneal lymph-node dissection in metastatic nonseminomatous germ-cell tumorsSebastiano Nazzani, Silvia Stagni, Davide Biasoni, et al.
Clinical Genitourinary Cancer|April 8, 2025
mRNA-Based Urine Test Performance in High and Very-High Risk Non-Muscle-Invasive Bladder Cancer Patients Undergoing Contextual Endoscopic Follow-up (VERNAL: Vesical Tumor Early Monitoring: mRNA-Based Follow-up)Alberto Macchi, Martina Bruniera, Sebastiano Nazzani, et al.
JCO Precision Oncology|August 18, 2025
Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to AbemaciclibAmedeo Nuzzo, Marco Barella, Melanie Claps, et al.
British Journal of Cancer|April 9, 2026
Salvage post-chemotherapy retroperitoneal lymph-node dissection: evolving paradigm for marker-positive non-seminomatous germ-cell tumors managementSebastiano Nazzani, Carlo Silvani, Cesare Saitta, et al.
Minerva Urology and Nephrology|January 27, 2026
Management of monorchid patients with previous testis cancer: the role of frozen sections and the real possibility of testis sparing surgery in a large retrospective seriesSebastiano Nazzani, Ruggero Darisi, Mario Catanzaro, et al.
Urologic Oncology|October 31, 2020
Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective studyPaolo Gontero, Andrea Mari, Giancarlo Marra, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2025
Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the "S1STeM 371" TrialSebastiano Nazzani, Adele Busico, Valentina Bernasconi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2023
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort studyLuca Antonelli, Davide Ardizzone, Praful Ravi, et al.
World Journal of Urology|June 4, 2025
UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesionCesare Saitta, Giuseppe Garofano, Giacomo Musso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual CancerLuca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 28, 2022
Laparoscopic retroperitoneal lymph-node dissection in metastatic nonseminomatous germ-cell tumorsSebastiano Nazzani, Silvia Stagni, Davide Biasoni, et al.
Clinical Genitourinary Cancer|April 8, 2025
mRNA-Based Urine Test Performance in High and Very-High Risk Non-Muscle-Invasive Bladder Cancer Patients Undergoing Contextual Endoscopic Follow-up (VERNAL: Vesical Tumor Early Monitoring: mRNA-Based Follow-up)Alberto Macchi, Martina Bruniera, Sebastiano Nazzani, et al.
JCO Precision Oncology|August 18, 2025
Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to AbemaciclibAmedeo Nuzzo, Marco Barella, Melanie Claps, et al.
British Journal of Cancer|April 9, 2026
Salvage post-chemotherapy retroperitoneal lymph-node dissection: evolving paradigm for marker-positive non-seminomatous germ-cell tumors managementSebastiano Nazzani, Carlo Silvani, Cesare Saitta, et al.
Minerva Urology and Nephrology|January 27, 2026
Management of monorchid patients with previous testis cancer: the role of frozen sections and the real possibility of testis sparing surgery in a large retrospective seriesSebastiano Nazzani, Ruggero Darisi, Mario Catanzaro, et al.
Urologic Oncology|October 31, 2020
Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective studyPaolo Gontero, Andrea Mari, Giancarlo Marra, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2025
Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the "S1STeM 371" TrialSebastiano Nazzani, Adele Busico, Valentina Bernasconi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2023
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort studyLuca Antonelli, Davide Ardizzone, Praful Ravi, et al.
World Journal of Urology|June 4, 2025
UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesionCesare Saitta, Giuseppe Garofano, Giacomo Musso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual CancerLuca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
Pageof 9